PZU:GPWPowszechny Zaklad Ubezpieczen Spolka Akcyjna Analysis
Data as of 2026-03-14 - not real-time
PLN 62.74
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PZU posted a record 2025 with premium growth of PLN 1.5 bn and a 25% jump in net profit, yet the stock slipped to PLN 62.74, hovering just above the calculated support of PLN 60.88. PE ratio of 7.95 is well below the industry average of 16.35, indicating a cheap valuation, while the dividend yield of 7.24% ranks among the highest in the sector. The balance sheet shows ample liquidity with PLN 48.7 bn cash versus PLN 45.4 bn debt, and a moderate debt‑to‑equity of 62.5%. Technicals are mixed: RSI at 34.9 points to oversold conditions, but a bearish MACD and neutral trend suggest limited upside in the near term. Volume is trending upward, supporting potential accumulation, and the 30‑day volatility of ~25% reflects a fairly active price environment.
The DCF model suggests a fair value far above the current price, but given the extreme discrepancy we rely more on relative metrics and the strong earnings backdrop. With a solid ROE of 20% and a sustainable payout ratio of 57%, the dividend appears durable. Overall, the stock appears undervalued on fundamentals, but short‑term price pressure near support and bearish momentum warrant cautious positioning.
The DCF model suggests a fair value far above the current price, but given the extreme discrepancy we rely more on relative metrics and the strong earnings backdrop. With a solid ROE of 20% and a sustainable payout ratio of 57%, the dividend appears durable. Overall, the stock appears undervalued on fundamentals, but short‑term price pressure near support and bearish momentum warrant cautious positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support
- Bearish MACD histogram
- Oversold RSI suggesting possible bounce
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Record earnings and profit growth
- High dividend yield with sustainable payout
- Valuation multiples well below peers
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong cash generation and low beta
- Robust solvency outlook (target 125%)
- Stable business model across insurance and ancillary services
Key Metrics & Analysis
Financial Health
Profit Margin10.58%
P/E Ratio8.0
ROE20.28%
ROA3.16%
Debt/Equity62.51
P/B Ratio1.5
Op. Cash FlowPLN10.5B
Free Cash FlowPLN19.4B
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI34.9
SupportPLN 60.88
ResistancePLN 70.20
MA 20PLN 66.66
MA 50PLN 68.63
MA 200PLN 63.02
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValuePLN 308.99
Target PricePLN 69.90
Upside/Downside11.41%
GradeUndervalued
TypeBlend
Dividend Yield7.24%
Risk Assessment
Beta0.48
Volatility25.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.